Articles

  • 1 week ago | upi.com | India Edwards

    A newly approved antibiotic to treat urinary tract infections may also help fight drug-resistant gonorrhea, a new study shows. The medication, called gepotidacin, could become the first new gonorrhea treatment since the 1990s. In an international study of more than 600 people, researchers found that it worked just as well as current standard treatments.

  • 3 weeks ago | miamiherald.com | India Edwards

    As a measles outbreak spreads across the United States, doctors are now seeing a new and unexpected danger: children getting sick from taking too much vitamin A. At Covenant Children's Hospital in Lubbock, Texas, several unvaccinated children showed signs of liver problems after taking large amounts of vitamin A, according to Dr. Lara Johnson, the hospital's chief medical officer. U.S. Department of Health and Human Services Secretary Robert F.

  • 1 month ago | upi.com | India Edwards

    In one study, Alnylam Pharmaceuticals' Amvuttra helped lower the risk of death and heart problems by 28% over three years compared to a placebo. The drug is given as a shot every three months. Adobe stock/HealthDay The U.S. Food and Drug Administration has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra (vutrisiran), is made by Alnylam Pharmaceuticals Inc. and is used to treat transthyretin amyloid cardiomyopathy.

  • 1 month ago | upi.com | India Edwards

    In January, the Florida Office of Insurance Regulation asked pharmacy benefit managers -- companies that manage prescription drug plans -- to hand over highly personal data about prescriptions filled in the state last year. Adobe stock/HealthDay Florida's insurance regulator is demanding detailed prescription data on millions of patients, raising alarms over patient privacy.

  • 1 month ago | heraldonline.com | India Edwards

    Men with strong, fast-swimming sperm may not only have better fertility, but also longer lives, a new study suggests. Researchers tracked more than 78,000 men over 50 years and found that those with higher sperm motility -- the ability of sperm to swim -- lived nearly three years longer than men with poor sperm movement.